Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design

Article ID	Journal	Published Year	Pages	File Type
8757514	Contemporary Clinical Trials	2018	37 Pages	PDF

Abstract

This trial is registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN000026635).

Keywords

Lubiprostone Non-alcoholic steatohepatitis Endotoxin non-alcoholic fatty liver disease Randomised Double blind Gut permeability Placebo controlled

Related Topics

Health Sciences Medicine and Dentistry Medicine and Dentistry (General)

Preview

Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design

Authors

Takaomi Kessoku, Kento Imajo, Takashi Kobayashi, Yasushi Honda, Takayuki Kato, Yuji Ogawa, Wataru Tomeno, Shingo Kato, Takuma Higurashi, Masato Yoneda, Hiroyuki Kirikoshi, Kazumi Kubota, Masataka Taguri, Takeharu Yamanaka, Haruki Usuda, Koichiro Wada,